Eli Lilly’s Latest Combination Antibody Therapy Yields Strong Effectiveness Against Covid-19 Eli Lilly is one of the pharmaceutical companies taking on the task of developing these therapies, and a new antibody therapy trial released last week proved one combination therapy to be quite effective at reducing viral load in Covid-19 patients.